Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
The FDA slapped Midmark Corp. with a "significant" warning letter after an inspection of its Versailles, Ohio, headquarters last year. The laundry list of violations from the watchdog agency focused primarily on manufacturing procedures and record-keeping issues related to the company’s steam sterilizer systems.
As public pressure mounts over the potential harm caused by transvaginal mesh implants the FDA ordered device makers, including Johnson & Johnson (NYSE:JNJ) and C.R. Bard (NYSE:BCR), to take another look at complication rates associated with their devices.
Welch Allyn president & CEO Julie Shimer announced plans to retire from the Skaneateles Falls, N.Y.-based diagnostics maker by the end of 2012. Shimer became the first woman to hold the corner office at the 95-year old company when she took the position in 2007 after 5 years on the med-tech maker’s board of directors.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.